The delay is another blow to the EU, which has also been hit by
delays in deliveries from Anglo-Swedish drugmaker AstraZeneca and
U.S. company Moderna, and had also faced earlier delays on the
Pfizer vaccine.
It also raises questions about the rationale of an EU vaccine export
control scheme which was set up in late January to ensure timely
deliveries but has not yet been activated, despite the supply
shortfalls.
By the middle of last week, Pfizer had delivered to the EU 23
million doses of the COVID-19 vaccine it developed with German firm
BioNTech, said an EU official who is directly involved in talks with
the U.S. company.
That was about 10 million doses less than Pfizer had promised to
supplied by mid-February, said a second official who is also
involved in the talks.
Pfizer declined to comment, saying schedules of its deliveries were
confidential. The executive European Commission did not respond to a
request for comment on delivery shortfalls.
EU officials have said Pfizer committed to delivering 3.5 million
doses a week from the start of January, for a total of 21 million
shots by mid-February.
In mid-January, there was a temporary hiccup in supplies which EU
officials say was largely resolved last month.. But a lot of doses
that were due to arrive in December are still missing, the two EU
officials said.
The Pfizer/BioNTech vaccine was approved for use in the EU on Dec.
21. The following day, BioNTech said the companies would ship to the
EU 12.5 million doses by the end of the month..
Only about 2 million of those doses due in December have been
delivered, according to Reuters calculations.
The shortfall would amount to about 30% of the total supplies
pledged for the period from December until mid-February.
One EU official said the company had committed to delivering the
missing doses by the end of March.
[to top of second column] |
The EU has two contracts with
Pfizer for the supply of 600 million vaccine
doses.
TRADE FLOWS
Although the EU's own supplies have fallen
short, the European Commission has approved all
requests for export of COVID-19 vaccines -
mostly from Pfizer/BioNTech - since it set up
its mechanism to monitor flows.
In the period between Jan. 30 and Feb. 16, the
EU gave the green light to 57 requests for
vaccine export to 24 countries, including
Britain and the United Arab Emirates (UAE), a
Commission spokeswoman said on Wednesday.
Before the monitoring scheme was set up, the bloc had already
exported millions of vaccines to Israel, Britain and Canada among
others, mostly Pfizer's, according to customs data cited in a EU
document seen by Reuters.
Israel has injected the first vaccine dose to more than 75% of its
population, figures from University of Oxford-based Our World in
Data show. The figure for the UAE is around 50% and for Britain it
is above 20%.
EU countries on average have vaccinated only about 5% of their
populations, according to Our World in Data.
Countries with a high number of inoculations are already vaccinating
people who are not among the most vulnerable, while those most in
need elsewhere have not yet had a shot.
The World Health Organization has set the target of inoculating 20%
of poor countries' population by the end of the year.
(Reporting by Francesco Guarascio @fraguarascio, Editing by Timothy
Heritage)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |